Ipca Laboratories Limited (NSE:IPCALAB)

India · Delayed Price · Currency is INR

1,502.60

+8.40 (0.56%)

Mar 9, 2026, 3:30 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals	89.41B	77.06B	62.48B	58.31B	54.21B
Pharmaceuticals Growth	16.03%	23.33%	7.16%	7.56%	16.58%
Total	89.41B	77.06B	62.48B	58.31B	54.21B
Total Growth	16.03%	23.33%	7.16%	7.56%	16.58%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	40.42B	36.14B	32.65B	30.11B	24.57B
India Growth	11.84%	10.68%	8.44%	22.56%	10.86%
outside India	48.98B	40.91B	29.79B	28.19B	29.63B
outside India Growth	19.72%	37.33%	5.69%	-4.88%	-
Total	89.40B	77.05B	62.44B	58.30B	54.20B
Total Growth	16.02%	23.39%	7.11%	7.56%	16.59%

Source: S&P Global Market Intelligence.